StockOtters
StockOttersSupply Chain Map
Hyundai Bioscience Co., Ltd. logo

Hyundai Bioscience Co., Ltd.

048410.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
11
Cost of Revenue
2
Gross Profit
9
Gross Margin
78.8%
Operating Income
1
Operating Margin
5.3%
Net Income
-5
Net Margin
-46.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-26.5%

2023

12/31/2023

Revenue
7
Cost of Revenue
3
Gross Profit
4
Gross Margin
53.2%
Operating Income
-7
Operating Margin
-103.2%
Net Income
-11
Net Margin
-152.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-10
EBITDA Margin
-134.5%

2022

12/31/2022

Revenue
6
Cost of Revenue
4
Gross Profit
1
Gross Margin
24.8%
Operating Income
-20
Operating Margin
-335.1%
Net Income
-12
Net Margin
-201.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-18
EBITDA Margin
-312.4%

2021

12/31/2021

Revenue
7
Cost of Revenue
6
Gross Profit
1
Gross Margin
16.5%
Operating Income
-7
Operating Margin
-100.5%
Net Income
-15
Net Margin
-217.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-11
EBITDA Margin
-153.6%

2020

12/31/2020

Revenue
9
Cost of Revenue
7
Gross Profit
3
Gross Margin
28.0%
Operating Income
-3
Operating Margin
-35.4%
Net Income
-6
Net Margin
-66.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-36.5%